NPORT-EX 2 VIPXC00VirtAvMulStraTRFd.htm
VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited)
January 31, 2021
($ reported in thousands)
  Shares   Value
Common Stocks—28.1%
Communication Services—4.2%    
Alphabet, Inc. Class A(1) 37   $68
Altice USA, Inc. Class A(1) 2,613   93
Bandwidth, Inc. Class A(1) 41   7
Cable One, Inc. 3   6
Cargurus, Inc.(1) 194   6
Charter Communications, Inc. Class A(1) 616   374
Comcast Corp. Class A 7,818   388
Elisa OYJ 571   34
Infrastrutture Wireless Italiane SpA 144A(2) 2,751   30
Liberty Broadband Corp. Class A(1) 42   6
Liberty Broadband Corp. Class C(1) 41   6
NetEase, Inc. ADR 613   70
New York Times Co. (The) Class A 126   6
Nintendo Co. Ltd. 100   58
Scout24 AG 144A(2) 407   31
Take-Two Interactive Software, Inc.(1) 30   6
TechTarget, Inc.(1) 95   7
Vodafone Group PLC 20,738   35
Zynga, Inc. Class A(1) 673   7
      1,238
       
 
Consumer Discretionary—1.8%    
Aristocrat Leisure Ltd. 275   6
Burlington Stores, Inc.(1) 279   69
Carnival PLC 1,889   30
Chipotle Mexican Grill, Inc.(1) 4   6
Crown Resorts Ltd. 218   2
Deckers Outdoor Corp.(1) 19   6
Delivery Hero SE 144A(1)(2) 199   30
Domino’s Pizza, Inc. 16   6
Dorman Products, Inc.(1) 64   6
EssilorLuxottica SA 203   29
Ferrari NV 146   30
Flutter Entertainment PLC(1) 152   28
Galaxy Entertainment Group Ltd. Class L 1,340   10
Garmin Ltd. 52   6
Gentex Corp. 172   6
Genting Singapore Ltd. 3,300   2
Grand Canyon Education, Inc.(1) 70   6
Hermes International 30   31
Just Eat Takeaway.com NV 144A(1)(2) 264   30
Kering SA 45   30
Lululemon Athletica, Inc.(1) 17   6
LVMH Moet Hennessy Louis Vuitton SE 50   30
McDonald’s Holdings Co. Japan Ltd. 100   5
Moncler SpA(1) 547   31
O’Reilly Automotive, Inc.(1) 13   5
Oriental Land Co. Ltd 100   16
  Shares   Value
       
Consumer Discretionary—continued    
Pool Corp. 16   $6
Prosus NV 301   35
Sands China Ltd. 1,491   6
SJM Holdings Ltd. 1,417   1
Tabcorp Holdings Ltd. 1,013   3
Tractor Supply Co. 42   6
Vivint Smart Home, Inc.(1) 273   5
Wingstop, Inc. 44   7
Wynn Macau Ltd.(1) 651   1
Yum China Holdings, Inc. 110   6
      538
       
 
Consumer Staples—1.3%    
Beiersdorf AG 280   31
Boston Beer Co., Inc. (The) Class A(1) 7   6
Brown-Forman Corp. Class A 87   6
Brown-Forman Corp. Class B 82   6
Cal-Maine Foods, Inc.(1) 166   6
Church & Dwight Co., Inc. 74   6
Clorox Co. (The) 33   7
Constellation Brands, Inc. Class A 325   69
Davide Campari-Milano NV 3,013   33
Flowers Foods, Inc. 285   7
Freshpet, Inc.(1) 43   6
Henkel AG & Co. KGaA 290   30
Hershey Co. (The) 43   6
Hormel Foods Corp. 142   7
J&J Snack Foods Corp. 41   6
John B Sanfilippo & Son, Inc. 80   7
Kerry Group PLC Class A 223   30
Lancaster Colony Corp. 36   6
L’Oreal SA 86   30
McCormick & Co., Inc. 67   6
Pernod Ricard SA 168   32
Remy Cointreau SA 179   33
Sanderson Farms, Inc. 46   6
Tootsie Roll Industries, Inc. 210   8
WD-40 Co. 21   6
      396
       
 
Energy—0.6%    
BP PLC 9,640   36
Koninklijke Vopak NV 628   32
Neste OYJ 427   30
Reliance Industries Ltd. 1,910   48
TOTAL SE 798   34
      180
       
 
Financials—3.3%    
Aon PLC Class A 430   87
Arch Capital Group Ltd.(1) 4,309   135
AXA SA 1,722   38
Banco Santander SA(1) 10,864   32
Brown & Brown, Inc. 645   28
Credicorp Ltd. 405   61
Everest Re Group Ltd. 322   68
  Shares   Value
       
Financials—continued    
Gallagher (Arthur J.) & Co. 768   $89
Marsh & McLennan Cos., Inc. 765   84
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen 247   65
RenaissanceRe Holdings Ltd. 453   68
SCOR SE(1) 987   30
Societe Generale SA(1) 1,687   32
Standard Chartered PLC(1) 5,357   33
UniCredit SpA(1) 3,731   34
Willis Towers Watson PLC 422   86
      970
       
 
Health Care—3.5%    
10X Genomics, Inc. Class A(1) 38   7
ABIOMED, Inc.(1) 19   7
ACADIA Pharmaceuticals, Inc.(1) 116   6
Acceleron Pharma, Inc. (1) 54   6
Agilent Technologies, Inc. 49   6
Allakos, Inc.(1) 50   7
Alnylam Pharmaceuticals, Inc.(1) 40   6
Amedisys, Inc.(1) 21   6
Arena Pharmaceuticals, Inc.(1) 85   6
Argenx SE(1) 118   35
AtriCure, Inc.(1) 106   6
Atrion Corp. 9   6
Axonics Modulation Technologies, Inc.(1) 121   6
Axsome Therapeutics, Inc.(1) 81   6
Bio-Rad Laboratories, Inc. Class A(1) 10   6
Bio-Techne Corp. 19   6
Black Diamond Therapeutics, Inc.(1) 181   5
Cardiovascular Systems, Inc.(1) 139   6
CareDx, Inc.(1) 78   6
Carl Zeiss Meditec AG 233   36
Castle Biosciences, Inc.(1) 82   5
Cerner Corp. 78   6
Chemed Corp. 11   6
ChemoCentryx, Inc.(1) 101   6
Codexis, Inc.(1) 278   6
Cooper Cos., Inc. (The) 18   7
CryoPort, Inc.(1) 113   8
Deciphera Pharmaceuticals, Inc.(1) 117   5
DiaSorin SpA 165   36
Eagle Pharmaceuticals, Inc.(1) 126   6
Enanta Pharmaceuticals, Inc.(1) 126   6
Exelixis, Inc.(1) 261   6
See Notes to Schedule of Investments
1

VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
January 31, 2021
($ reported in thousands)
  Shares   Value
       
Health Care—continued    
Globus Medical, Inc. Class A(1) 94   $6
Guardant Health, Inc.(1) 41   6
Haemonetics Corp.(1) 50   6
Halozyme Therapeutics, Inc.(1) 147   7
HMS Holdings Corp.(1) 172   6
ICU Medical, Inc.(1) 28   6
IDEXX Laboratories, Inc.(1) 12   6
Immunovant, Inc.(1) 135   5
Incyte Corp.(1) 68   6
Inspire Medical Systems, Inc.(1) 32   6
Insulet Corp.(1) 25   7
Ionis Pharmaceuticals, Inc.(1) 101   6
Iovance Biotherapeutics, Inc.(1) 123   5
Karuna Therapeutics, Inc.(1) 59   6
Kodiak Sciences, Inc.(1) 42   5
Koninklijke Philips NV(1) 583   32
Krystal Biotech, Inc.(1) 95   7
Kura Oncology, Inc.(1) 169   5
LeMaitre Vascular, Inc. 153   7
LHC Group, Inc.(1) 30   6
Madrigal Pharmaceuticals, Inc.(1) 55   7
Masimo Corp.(1) 22   6
Mesa Laboratories, Inc. 22   6
Mettler-Toledo International, Inc.(1) 5   6
Mirati Therapeutics, Inc.(1) 30   6
Neogen Corp.(1) 75   6
NeoGenomics, Inc.(1) 118   6
Neurocrine Biosciences, Inc.(1) 56   6
Nevro Corp.(1) 37   6
Novocure Ltd.(1) 37   6
Omnicell, Inc.(1) 53   6
Orion Oyj Class B 702   32
Penumbra, Inc.(1) 31   8
PerkinElmer, Inc. 40   6
Phreesia, Inc.(1) 109   7
QIAGEN NV(1) 610   33
QIAGEN NV(1) 120   7
Recordati Industria Chimica e Farmaceutica SpA 613   32
Relmada Therapeutics, Inc.(1) 180   6
Repligen Corp.(1) 31   6
ResMed, Inc. 29   6
Sanofi 332   31
Sartorius Stedim Biotech 89   37
Seagen, Inc.(1) 35   6
Shockwave Medical, Inc.(1) 54   6
Siemens Healthineers AG 144A(2) 593   33
Silk Road Medical, Inc.(1) 106   6
Simulations Plus, Inc. 79   6
SpringWorks Therapeutics, Inc.(1) 96   8
STAAR Surgical Co.(1) 75   8
  Shares   Value
       
Health Care—continued    
STERIS PLC 31   $6
Stoke Therapeutics, Inc.(1) 108   7
Tandem Diabetes Care, Inc.(1) 66   6
Teladoc Health, Inc.(1) 29   8
Teleflex, Inc. 16   6
Thermo Fisher Scientific, Inc. 139   71
Turning Point Therapeutics, Inc.(1) 49   6
UCB SA 303   31
United Therapeutics Corp.(1) 37   6
Varian Medical Systems, Inc.(1) 36   6
Veeva Systems, Inc. Class A(1) 22   6
Veracyte, Inc.(1) 126   7
Vericel Corp.(1) 181   7
Viking Therapeutics, Inc.(1) 939   7
Waters Corp.(1) 24   6
West Pharmaceutical Services, Inc. 21   6
Y-mAbs Therapeutics, Inc.(1) 121   5
Zoetis, Inc. 401   62
      1,040
       
 
Industrials—6.7%    
A.O. Smith Corp. 112   6
AAON, Inc. 91   7
AeroVironment, Inc. (1) 68   8
Air China Ltd. Class H 10,069   7
Allegion PLC 873   93
AMETEK, Inc. 51   6
ANA Holdings, Inc.(1) 1,600   34
Assa Abloy AB Class B 5,936   147
Bouygues SA 852   34
Brady Corp. Class A 117   5
C.H. Robinson Worldwide, Inc. 65   6
Carrier Global Corp. 1,057   41
China Southern Airlines Co. Ltd. Class H(1) 14,000   8
Cintas Corp. 19   6
Copart, Inc.(1) 608   67
CoStar Group, Inc.(1) 7   6
CSW Industrials, Inc. 51   6
Daikin Industries Ltd. 400   84
Donaldson Co., Inc. 106   6
Encore Wire Corp. 104   6
Equifax, Inc. 715   127
Experian PLC 3,319   116
Exponent, Inc. 67   6
Fastenal Co. 121   6
Graco, Inc. 84   6
Heartland Express, Inc. 339   6
HEICO Corp. 46   5
HEICO Corp. Class A 52   6
Hunt (JB) Transport Services, Inc. 43   6
IDEX Corp. 29   5
  Shares   Value
       
Industrials—continued    
IHS Markit Ltd. 69   $6
Japan Airlines Co. Ltd.(1) 2,600   46
Johnson Controls International PLC 892   44
Kansas City Southern 29   6
Kingspan Group PLC(1) 400   27
Knorr-Bremse AG 229   30
Kone OYJ Class B 1,461   115
Landstar System, Inc. 42   6
Legrand SA 327   30
Lennox International, Inc. 156   43
Lincoln Electric Holdings, Inc. 52   6
Mercury Systems, Inc.(1) 78   6
MSA Safety, Inc. 40   6
Nordson Corp. 32   6
Old Dominion Freight Line, Inc. 31   6
Otis Worldwide Corp. 1,401   91
Proto Labs, Inc.(1) 35   7
Rational AG 36   35
Raven Industries, Inc. 172   6
Republic Services, Inc. 66   6
Rockwell Automation, Inc. 24   6
Rollins, Inc. 152   5
Safran SA(1)(3)(4) 246   31
Schindler Holding AG 343   91
Schneider Electric SE 207   30
Simpson Manufacturing Co., Inc. 62   6
Singapore Airlines Ltd.(1) 2,600   8
Teledyne Technologies, Inc.(1) 17   6
Teleperformance 97   32
Toro Co. (The) 63   6
Trane Technologies PLC 394   57
TransUnion 1,345   117
Trex Co., Inc.(1) 70   6
UniFirst Corp. 29   6
Union Pacific Corp. 324   64
Verisk Analytics, Inc. 33   6
Vicor Corp.(1) 63   5
W.W. Grainger, Inc. 16   6
Watsco, Inc. 203   48
Watts Water Technologies, Inc. Class A 50   6
Wolters Kluwer NV 374   31
      1,973
       
 
Information Technology—5.4%    
Acacia Communications, Inc.(1) 77   9
Adyen NV 144A(1)(2) 15   31
Akamai Technologies, Inc.(1) 62   7
Alarm.com Holdings, Inc.(1) 60   6
Altair Engineering, Inc. Class A(1) 102   6
Ambarella, Inc.(1) 59   6
Amdocs Ltd. 90   6
Amphenol Corp. Class A 46   6
ANSYS, Inc.(1) 17   6
See Notes to Schedule of Investments
2

VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
January 31, 2021
($ reported in thousands)
  Shares   Value
       
Information Technology—continued    
Appfolio, Inc. Class A(1) 39   $6
Arista Networks, Inc.(1) 21   6
ASML Holding NV 63   34
Aspen Technology, Inc.(1) 45   6
Avalara, Inc.(1) 40   6
Badger Meter, Inc. 61   6
Black Knight, Inc.(1) 73   6
Blackline, Inc.(1) 49   6
Booz Allen Hamilton Holding Corp. 69   6
Broadcom, Inc. 144   65
Broadridge Financial Solutions, Inc. 41   6
Cadence Design Systems, Inc.(1) 47   6
Capgemini SE 270   39
CEVA, Inc.(1) 116   7
Cirrus Logic, Inc.(1) 69   6
Citrix Systems, Inc. 49   7
Cloudflare, Inc. Class A(1) 82   6
Cognex Corp. 73   6
Crowdstrike Holdings, Inc. Class A(1) 27   6
Dassault Systemes SE 159   32
Datadog, Inc. Class A(1) 60   6
DocuSign, Inc.(1) 27   6
Dolby Laboratories, Inc. Class A 65   6
Elastic N.V.(1) 42   6
Entegris, Inc. 62   6
EPAM Systems, Inc.(1) 18   6
F5 Networks, Inc.(1) 33   6
Fair Isaac Corp.(1) 12   5
Five9, Inc.(1) 37   6
Globant SA(1) 28   5
Guidewire Software, Inc.(1) 48   6
HubSpot, Inc.(1) 16   6
Infineon Technologies AG 1,099   44
Jack Henry & Associates, Inc. 38   6
Keysight Technologies, Inc.(1) 42   6
Lattice Semiconductor Corp.(1) 143   6
Lumentum Holdings, Inc.(1) 679   64
Manhattan Associates, Inc.(1) 55   6
Marvell Technology Group Ltd. 125   6
Maxim Integrated Products, Inc. 66   6
MAXIMUS, Inc. 82   6
Micron Technology, Inc.(1) 1,276   100
Mitek Systems, Inc.(1) 368   6
Monolithic Power Systems, Inc. 16   6
Murata Manufacturing Co. Ltd. 1,600   154
National Instruments Corp. 135   6
NIC, Inc. 231   6
Novanta, Inc.(1) 48   6
  Shares   Value
       
Information Technology—continued    
Okta, Inc.(1) 25   $6
Paychex, Inc. 69   6
Pegasystems, Inc. 45   6
Power Integrations, Inc. 67   5
PTC, Inc.(1) 49   7
Q2 Holdings, Inc.(1) 50   6
Qorvo, Inc.(1) 382   65
QUALCOMM, Inc. 417   65
Qualys, Inc.(1) 52   7
RingCentral, Inc. Class A(1) 16   6
Samsung Electronics Co., Ltd. 1,666   122
Semtech Corp.(1) 84   6
SK Hynix, Inc. 1,027   112
Skyworks Solutions, Inc. 444   75
SPS Commerce, Inc.(1) 56   6
Synopsys, Inc.(1) 24   6
Teradyne, Inc. 46   5
Twilio, Inc. Class A(1) 17   6
Tyler Technologies, Inc.(1) 15   6
Universal Display Corp. 26   6
Varonis Systems, Inc.(1) 36   6
VeriSign, Inc.(1) 32   6
VirnetX Holding Corp. 1,277   8
Visa, Inc. Class A 305   59
Win Semiconductors Corp. 7,000   103
Xilinx, Inc. 42   6
Zendesk, Inc.(1) 41   6
      1,578
       
 
Materials—0.8%    
Air Liquide SA 193   32
Akzo Nobel NV 287   29
Anglo American PLC 1,004   33
AptarGroup, Inc. 45   6
Balchem Corp. 49   5
Fuchs Petrolub SE 572   33
Koninklijke DSM NV 185   32
NewMarket Corp. 15   6
Novagold Resources, Inc.(1) 651   6
Royal Gold, Inc. 59   6
Symrise AG 246   31
UPM-Kymmene OYJ 839   30
      249
       
 
Real Estate—0.5%    
Alexandria Real Estate Equities, Inc. 402   67
Rexford Industrial Realty, Inc. 1,308   64
      131
       
 
Total Common Stocks
(Identified Cost $6,754)
  8,293
       
 
       
 
  Shares   Value
       
       
Exchange-Traded Fund—4.1%
Invesco DB Gold Fund 22,714   $1,212
Total Exchange-Traded Fund
(Identified Cost $1,250)
  1,212
       
 
       
 
Purchased Options—1.3%
(See open purchased options schedule)    
Total Purchased Options
(Premiums paid $678)
  396
       
 
       
 
Total Long-Term Investments—33.5%
(Identified Cost $8,682)
  9,901
       
 
       
 
Short-Term Investment—31.9%
Money Market Mutual Fund—31.9%
Dreyfus Government Cash Management Fund - Institutional Shares (seven-day effective yield 0.030%)(5) 9,423,811   9,424
Total Short-Term Investment
(Identified Cost $9,424)
  9,424
       
 
       
 
TOTAL INVESTMENTS, BEFORE WRITTEN OPTIONS65.4%
(Identified Cost $18,106)
  19,325
       
 
       
 
Written Options—(1.6)%
(See open written options
schedule)
     
Total Written Options
(Premiums received $568)
  (489)
       
 
       
 
TOTAL INVESTMENTS, NET OF WRITTEN OPTIONS—63.8%
(Identified Cost $17,538)
  $18,836
Other assets and liabilities, net—36.2%   10,690
NET ASSETS—100.0%   $29,526
    
Abbreviations:
ADR American Depositary Receipt
LIBOR London Interbank Offered Rate
PLC Public Limited Company
QTR Quarterly
TERM Payment Frequency at Termination
    
See Notes to Schedule of Investments
3

VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
January 31, 2021
($ reported in thousands)
Footnote Legend:
(1) Non-income producing.
(2) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At January 31, 2021, these securities amounted to a value of $185 or 0.6% of net assets.
(3) Security valued at fair value as determined in good faith by or under the direction of the Trustees.
(4) Restricted security.
(5) Shares of this fund are publicly offered, and its prospectus and annual report are publicly available.
    
Counterparties:  
BNP BNP Paribas
CITI Citibank
GS Goldman Sachs & Co.
JPM JPMorgan Chase Bank N.A.
ML Merrill Lynch
Soc Gen Societe Generale
    
Foreign Currencies:  
AUD Australian Dollar
BRL Brazilian Real
CHF Swiss Franc
CLP Chilean Peso
CNY Chinese Yuan
EUR Euro
GBP United Kingdom Pound Sterling
HKD Hong Kong Dollar
INR Indian Rupee
JPY Japanese Yen
KRW South Korean Won
MXN Mexican Peso
RUB Russian Ruble
SEK Swedish Krona
TWD Taiwan Dollar
USD United States Dollar
    
Country Weightings
United States 77%
France 4
Ireland 2
Germany 2
Netherlands 2
Japan 2
Bermuda 2
Other 9
Total 100%
% of total investments, net of written options, as of January 31, 2021.
Open purchased option contracts as of January 31, 2021 were as follows:
Description of Options Counterparty Number of
Contracts
Contract
Notional
Amount
Strike
Price(1)
Expiration
Date
Value
Call Options            
Euro Stoxx 50® Index JPM 147 $551 $75.00 03/19/21 $18
Euro Stoxx 600® Energy JPM 22 264 240.00 03/19/21 14
Russell 2000® Index JPM 10 2,100 2,100.00 03/19/21 94
Euro Stoxx 50® Index JPM 52 1,924 3,700.00 03/19/21 16
FTSE 100 Index JPM 70 4,900 7,000.00 03/19/21 9
Euro Stoxx 50® Index JPM 47 1,622 3,450.00 02/19/21 59
S&P 500® Index JPM 11 4,268 3,880.00 03/19/21 58
Nikkei 225 Index JPM 18 522,000 29,000.00 03/12/21 50
Euro Stoxx 50® Index JPM 56 218 78.00 03/19/21 4
Euro Stoxx 600® Energy JPM 40 510 255.00 03/19/21 12
Put Options            
MSCI Emerging Markets Index JPM 6 780 1,300.00 06/18/21 42
S&P 500® Index JPM 8 2,440 3,050.00 02/19/21 5
Euro Stoxx 50® Index JPM 69 2,001 2,900.00 02/19/21 5
MSCI Emerging Markets Index JPM 3 390 1,300.00 03/19/21 10
Total $396
    
Footnote Legend:
(1) Strike price not reported in thousands.
    
See Notes to Schedule of Investments
4

VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
January 31, 2021
($ reported in thousands)
Open written option contracts as of January 31, 2021 were as follows:
Description of Options Counterparty Number of
Contracts
Contract
Notional
Amount
Strike
Price(1)
Expiration
Date
Value
Call Options            
Euro Stoxx 50® Index JPM 52 $2,002 $3,850.00 03/19/21 $(2)
Euro Stoxx 50® Index JPM 47 1,715 3,650.00 02/19/21 (8)
FTSE 100 Index JPM 70 4,970 7,100.00 03/19/21 (5)
Nikkei 225 Index JPM 18 531,000 29,500.00 03/12/21 (31)
S&P 500® Index JPM 11 4,378 3,980.00 03/19/21 (22)
MSCI Emerging Markets Index JPM 6 870 1,450.00 06/18/21 (25)
S&P 500® Index JPM 3 1,192 3,975.00 02/05/21 (—)(2)
Russell 2000® Index JPM 10 2,200 2,200.00 03/19/21 (42)
MSCI Emerging Markets Index JPM 3 428 1,425.00 03/19/21 (5)
Put Options            
Nikkei 225 Index JPM 2 51,500 25,750.00 03/12/21 (8)
S&P 500® Index JPM 3 1,080 3,600.00 03/19/21 (34)
Euro Stoxx 50® Index JPM 147 551 75.00 03/19/21 (58)
Euro Stoxx 50® Index JPM 26 897 3,450.00 03/19/21 (36)
Euro Stoxx 600® Energy JPM 22 264 240.00 03/19/21 (17)
Russell 2000® Index JPM 5 995 1,990.00 03/19/21 (38)
FTSE 100 Index JPM 10 650 6,500.00 03/19/21 (37)
MSCI Emerging Markets Index JPM 6 720 1,200.00 06/18/21 (27)
Euro Stoxx 50® Index JPM 19 608 3,200.00 02/19/21 (5)
MSCI Emerging Markets Index JPM 3 360 1,200.00 03/19/21 (5)
Euro Stoxx 50® Index JPM 56 219 78.00 03/19/21 (30)
Euro Stoxx 600® Energy JPM 40 510 255.00 03/19/21 (54)
Total $(489)
    
Footnote Legend:
(1) Strike price not reported in thousands.
(2) Amount is less than $500.
    
Futures contracts as of January 31, 2021 were as follows:
Issue Expiration Contracts
Purchased/(Sold)
Notional Value Value/Unrealized
Appreciation
(Depreciation)
10 Year Commonwealth Treasury Bond Future March 2021 42 $4,682 $(42)
10 Year U.S. Treasury Note Future March 2021 63 8,633 (56)
Euro Stoxx 50® Future March 2021 (42) (1,773) 45
Euro Stoxx 600® Future March 2021 (11) (263) (4)
MSCI All Country World Index Future March 2021 (38) (1,247) (39)
MSCI Emerging Markets Index Future March 2021 19 1,260 68
MSCI World Index Future March 2021 (28) (2,231) (51)
MSCI World Industrials Future March 2021 13 1,107 (49)
Russell 2000® Future March 2021 (15) (1,551) (115)
S&P 500® Index E-Mini Future March 2021 5 926 10
S&P 500® Annual Dividend Index Future December 2021 21 306 35
S&P 500® Annual Dividend Index Future December 2022 20 297 40
Total $(158)
    
See Notes to Schedule of Investments
5

VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
January 31, 2021
($ reported in thousands)
Forward foreign currency exchange contracts as of January 31, 2021 were as follows:
Currency
Purchased
Value(1) Currency
Sold
Value(1) Counterparty Settlement
Date
Unrealized
Appreciation
  Unrealized
(Depreciation)
BRL(2) 3,959 USD 779 GS 02/17/21 $—   $(56)
CLP(2) 461,472 USD 631 BNP 02/17/21   (3)
CLP(2) 92,822 USD 126 Soc Gen 02/17/21 (3)  
EUR(2) 1,692 USD 2,083 CITI 02/17/21   (29)
EUR(2) 32 USD 39 GS 02/17/21   (—)(3)
EUR(2) 325 USD 395 JPM 02/17/21   (1)
EUR(2) 79 USD 96 Soc Gen 02/17/21   (—)(3)
GBP(2) 79 USD 108 Soc Gen 02/17/21   (—)(3)
JPY(2) 400,681 USD 3,902 ML 02/17/21   (76)
MXN(2) 7,760 USD 387 JPM 02/17/21   (9)
RUB(2) 39,501 USD 513 BNP 02/24/21 7  
RUB(2) 19,714 USD 256 CITI 02/24/21 4  
USD(2) 174 BRL 954 Soc Gen 02/17/21   (—)(3)
USD(2) 94 CHF 82 JPM 02/17/21 2  
USD(2) 151 CLP 110,984 BNP 02/17/21   (—)(3)
USD(2) 3,140 EUR 2,566 CITI 02/17/21 25  
USD(2) 91 EUR 75 GS 02/17/21   (—)(3)
USD(2) 882 EUR 722 JPM 02/17/21 5  
USD(2) 1 EUR 1 ML 02/17/21   (—)(3)
USD(2) 474 GBP 348 CITI 02/17/21   (2)
USD(2) 508 GBP 374 GS 02/17/21   (5)
USD(2) 50 HKD 389 Soc Gen 02/17/21 (3)  
USD(2) 48 INR 3,534 Soc Gen 02/17/21   (—)(3)
USD(2) 742 JPY 77,725 GS 02/17/21   (—)(3)
USD(2) 505 JPY 51,870 ML 02/17/21 10  
USD(2) 132 JPY 13,702 Soc Gen 02/17/21 1  
USD(2) 342 KRW 371,666 ML 02/17/21 10  
USD(2) 84 MXN 1,705 CITI 02/17/21 1  
USD(2) 155 SEK 1,264 JPM 02/17/21 4  
USD(2) 142 TWD 3,932 CITI 02/17/21 2  
USD(2) 163 RUB 12,335 BNP 02/24/21 1  
Total $72   $(181)
    
Footnote Legend:
(1) Reported in thousands.
(2) Non deliverable forward.
(3) Amount is less than $500.
    
Centrally Cleared credit default swaps - sell protection(1) outstanding as of January 31, 2021 was as follows:
Reference Entity Payment
Frequency
Counterparty Fixed
Rate
Expiration
Date
Notional
Amount(2)
Value   Premiums
Paid
(Received)
  Unrealized
Appreciation
  Unrealized
(Depreciation)
iTraxx Europe QTR JPM 5.000% 12/20/25 451 EUR $60   $34   $27   $—
Total $60   $34   $27   $—
    
Footnote Legend:
(1) If the Fund is a seller of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying investments comprising the referenced index or (ii) pay a net settlement amount in the form of cash or investments equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying investments comprising the referenced index.
(2) The maximum potential amount the Fund could be required to pay as a seller of credit protection or receive as a buyer of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.
    
See Notes to Schedule of Investments
6

VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
January 31, 2021
($ reported in thousands)
Centrally cleared inflation swaps outstanding as of January 31, 2021 were as follows:
Fixed
Rate
Floating
Rate
Payment
Frequency
Counterparty Expiration
Date
Notional
Amount
Value   Premiums
Paid
(Received)
  Unrealized
Appreciation
  Unrealized
Depreciation
1.807%(1) 1-Month-USCPI TERM JPM 07/28/50 144 USD $29   $—   $29   $—
1.828%(1) 1-Month-USCPI TERM JPM 07/28/50 144 USD 28     28  
1.810%(1) 1-Month-USCPI TERM JPM 07/29/50 144 USD 29     29  
2.317%(1) 1-Month-USCPI TERM JPM 01/14/51 29 USD (2)     (2)  
Total  $86   $—   $86   $—
    
Footnote Legend:
(1) Fund pays the fixed rate and receives the floating rate.
(2) Amount is less than $500.
    
Centrally cleared interest rate swaps outstanding as of January 31, 2021 were as follows:
Fixed
Rate
Floating
Rate
Payment
Frequency
Counterparty Expiration
Date
Notional
Amount
Value   Premiums
Paid
(Received)
  Unrealized
Appreciation
  Unrealized
Depreciation
2.880%(1) China Fixing Repo Rates 7 Days TERM JPM 12/16/25 13,044 CNY $10   $—   $10   $—
2.883%(1) China Fixing Repo Rates 7 Days TERM JPM 12/16/25 15,361 CNY 12     12  
2.875%(1) China Fixing Repo Rates 7 Days TERM JPM 12/16/25 9,492 CNY 7     7  
2.825%(1) China Fixing Repo Rates 7 Days TERM JPM 12/16/25 15,576 CNY 6     6  
0.504%(1) Australian Bank Bill TERM JPM 03/15/25 5,878 AUD (3)       (3)
0.493%(1) Australian Bank Bill TERM JPM 03/15/25 5,878 AUD (3)       (3)
0.527%(1) Australian Bank Bill TERM JPM 03/15/25 5,878 AUD      
Total  $29   $—   $35   $(6)
    
Footnote Legend:
(1) Fund pays the floating rate and receives the fixed rate.
    
Over-the-counter variance swaps outstanding as of January 31, 2021 were as follows:
Referenced Entity Strike
Price
Payment
Frequency
Counterparty Expiration
Date
Notional
Amount
Value   Premiums
Paid
(Received)
  Unrealized
Appreciation
  Unrealized
Depreciation
S&P 500® Composite Stock Price Index(1) $29.70 TERM GS 06/18/21 41 USD $86   $—   $86   $—
S&P 500® Composite Stock Price Index(2) 27.70 TERM ML 06/18/21 21 USD (9)       (9)
Total  $77   $—   $86   $(9)
    
Footnote Legend:
(1) Fund pays the fixed strike price and receives the variance payment.
(2) Fund pays the variance payment and receives the fixed strike price.
    
See Notes to Schedule of Investments
7

VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
January 31, 2021
($ reported in thousands)
Over-the-counter total return swaps outstanding as of January 31, 2021 were as follows:
Referenced Entity Floating Rate(1) Payment
Frequency
Counterparty Expiration
Date
Notional
Amount
Value   Premiums
Paid
(Received)
  Unrealized
Appreciation
  Unrealized
Depreciation
MSCI EMU Net Total Return EUR Index 1-Month LIBOR Monthly ML 07/09/21 900 EUR $45   $—   $45   $
MSCI World Industrials Net Total Return USD Index 1-Month LIBOR Monthly Soc Gen 09/08/21 807 USD 43     43  
Lixil Corp. 1-Month LIBOR Monthly BNP 11/29/21 2,485 JPY (2)     (2)  
Nitto Boseki Co. Ltd. 1-Month LIBOR Monthly BNP 12/03/21 2,630 JPY (2)       (2)
Discovery, Inc. 1-Month LIBOR Monthly ML 01/13/22 76 USD (10)       (10)
Walt Disney Co. 1-Month LIBOR Monthly ML 01/13/22 41 USD 2     2  
Fox Corp. 1-Month LIBOR Monthly ML 01/13/22 51 USD (1)       (1)
Lumen Technologies, Inc. 1-Month LIBOR Monthly ML 01/13/22 44 USD (8)       (8)
Netflix, Inc. 1-Month LIBOR Monthly ML 01/13/22 16 USD (1)       (1)
AT&T, Inc. 1-Month LIBOR Monthly ML 01/13/22 85 USD (—)(2)       (—)(2)
ViacomCBS, Inc. 1-Month LIBOR Monthly ML 01/13/22 65 USD (8)       (8)
Verizon Communications, Inc. 1-Month LIBOR Monthly ML 01/13/22 71 USD 3     3  
Fox Corp. 1-Month LIBOR Monthly Soc Gen 01/12/22 18 USD (—)(2)       (—)(2)
Verizon Communications, Inc. 1-Month LIBOR Monthly Soc Gen 01/12/22 73 USD 3     3  
Netflix, Inc. 1-Month LIBOR Monthly Soc Gen 01/12/22 57 USD (4)       (4)
ViacomCBS, Inc. 1-Month LIBOR Monthly Soc Gen 01/12/22 13 USD (2)       (2)
AT&T, Inc. 1-Month LIBOR Monthly Soc Gen 01/12/22 54 USD (2)     (2)  
Walt Disney Co. 1-Month LIBOR Monthly Soc Gen 01/12/22 33 USD 1     1  
Lumen Technologies, Inc. 1-Month LIBOR Monthly Soc Gen 01/12/22 19 USD (4)       (4)
MSCI EMU Net Total Return EUR Index 1-Month LIBOR Monthly ML 07/09/21 70 EUR 2     2  
Total  $59   $—   $99   $(40)
    
Footnote Legend:
(1) The Fund pays the floating rate (+/- a spread) and receives the total return of the reference entity.
(2) Amount is less than $500.
See Notes to Schedule of Investments
8

VIRTUS Aviva Multi-Strategy Target Return Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
January 31, 2021
($ reported in thousands)
The following table summarizes the market value of the Fund’s investments as of January 31, 2021, based on the inputs used to value them (See Security Valuation Note 1 in the Notes to Schedule of Investments):
  Total
Value at
January 31, 2021
  Level 1
Quoted Prices
  Level 2
Significant
Observable
Inputs
Assets:          
Equity Securities:          
Common Stocks $8,293   $7,426   $867
Exchange-Traded Fund 1,212   1,212  
Money Market Mutual Fund 9,424   9,424  
Other Financial Instruments:          
Purchased Options 396   396  
Futures Contracts 198   198  
Forward Foreign Currency Exchange Contracts 72     72
Centrally Cleared Inflation Swaps 86     86
Centrally Cleared Interest Rate Swaps 35     35
Over-the-Counter Total Return Swaps 99     99
Over-the-Counter Variance swaps 86     86
Centrally Cleared Credit Default Swap 60     60
Total Assets 19,961   18,656   1,305
Liabilities:          
Other Financial Instruments:          
Written Options (489)   (489)  
Futures Contracts (356)   (356)  
Forward Foreign Currency Exchange Contracts (181)     (181)
Centrally Cleared Interest Rate Swaps (6)     (6)
Over-the-Counter Variance swaps (9)     (9)
Over-the-Counter Total Return Swaps (40)     (40)
Total Liabilities (1,081)   (845)   (236)
Total Investments $18,880   $17,811   $1,069
There were no securities valued using significant unobservable inputs (Level 3) at January 31, 2021.
There were no transfers into or out of Level 3 related to securities held at January 31, 2021.
See Notes to Schedule of Investments
9

VIRTUS AVIVA MULTI-STRATEGY TARGET RETURN FUND
NOTES TO SCHEDULE OF INVESTMENTS (Unaudited)
January 31, 2021
Note 1. Security Valuation
The Fund utilizes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The Fund’s policy is to recognize transfers into or out of Level 3 at the end of the reporting period.
Level 1 – quoted prices in active markets for identical securities (security types generally include listed equities).
Level 2 – prices determined using other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3 – prices determined using significant unobservable inputs (including the Valuation Committee’s own assumptions in determining the fair value of investments).
A description of the valuation techniques applied to the Fund’s major categories of assets and liabilities measured at fair value on a recurring basis is as follows:
Equity securities are valued at the official closing price (typically last sale) on the exchange on which the securities are primarily traded or, if no closing price is available, at the last bid price and are categorized as Level 1 in the hierarchy. Restricted equity securities and private placements that are illiquid or are internally fair valued by the Valuation Committee, are generally categorized as Level 3 in the hierarchy.
Certain non-U.S. securities may be fair valued in cases where closing prices are not readily available or are deemed not reflective of readily available market prices. For example, significant events (such as movement in the U.S. securities market, or other regional and local developments) may occur between the time that non-U.S. markets close (where the security is principally traded) and the time that the Fund calculates its net asset value (“NAV”) at the close of regular trading on the New York Stock Exchange (“NYSE”) (generally 4 p.m. Eastern time) that may impact the value of securities traded in these non-U.S. markets. In such cases, the Fund fair values non-U.S. securities using an independent pricing service which considers the correlation of the trading patterns of the non-U.S. security to the intraday trading in the U.S. markets for investments such as American Depository Receipts, financial futures, exchange-traded funds (“ETFs”), and certain indexes, as well as prices for similar securities. Such fair valuations are categorized as Level 2 in the hierarchy. Because the frequency of significant events is not predictable, fair valuation of certain non-U.S. common stocks may occur on a frequent basis.
Debt securities, including restricted securities, are valued based on evaluated quotations received from independent pricing services or from dealers who make markets in such securities. For most bond types, the pricing service utilizes matrix pricing that considers one or more of the following factors: yield or price of bonds of comparable quality, coupon, maturity, current cash flows, type, and current day trade information, as well as dealer supplied prices. These valuations are generally categorized as Level 2 in the hierarchy. Structured debt instruments, such as mortgage-backed and asset-backed securities may also incorporate collateral analysis and utilize cash flow models for valuation and are generally categorized as Level 2 in the hierarchy. Pricing services do not provide pricing for all securities and therefore indicative bids from dealers are utilized which are based on pricing models used by market makers in the security and are generally categorized as Level 2 in the hierarchy. Debt securities that are internally fair valued by the Valuation Committee are generally categorized as Level 3 in the hierarchy.
Listed derivatives, such as options and futures, that are actively traded are valued at the last posted settlement price from the exchange where they are principally traded and are categorized as Level 1 in the hierarchy. Over-the-counter (“OTC”) derivative contracts, which include forward currency contracts, swaps, swaptions, options and equity linked instruments, are valued based on model prices provided by independent pricing services or from dealer quotes. Depending on the derivative type and the specific terms of the transaction, these models vary and include observable inputs in actively quoted markets including but not limited to: underlying reference entity details, indices, spreads, interest rates, yield curves, dividend and exchange rates. These instruments are generally categorized as Level 2 in the hierarchy. Centrally cleared swaps listed or traded on a bilateral or trade facility platform, such as a registered exchange, are valued at the last posted settlement price determined by the respective exchange. These securities are generally categorized as Level 2 within the hierarchy.
Investments in open-end mutual funds are valued at NAV. Investments in closed-end funds and ETFs are valued as of the close of regular trading on the NYSE each business day. Each is categorized as Level 1 in the hierarchy.
A summary of the inputs used to value the Fund’s net assets by each major security type is disclosed at the end of the Schedule of Investments for the Fund. The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
Note 2. Subsequent Events
Management has evaluated the impact of all subsequent events on the Fund through the date the report was available for issuance, and has determined that the following subsequent event requires recognition or disclosure in the report.
Effective February 26, 2021, the Aviva Multi-Strategy Target Return Fund was liquidated.
For additional information about significant accounting policies, refer to the Fund’s most recent semi or annual report.
10